Safety and Efficacy study of M2951 in Subjects with Rheumatoid Arthritis

Update Il y a 4 ans
Reference: EUCTR2016-000064-42

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To assess the efficacy of M2951 in subjects with active RA on stable MTX therapy, as measured by the American College of Rheumatology (ACR) 20% (ACR20) response rate over a duration of 84 days.


Inclusion criteria

  • Rheumatoid Arthritis